|
|

Title: Liposomal delivery by iontophoresis
United States Patent: 6,048,545
Inventors: Keller; Brian C. (Antioch, CA); Fisher; Daniel L.
(Pleasant Hill, CA); Kiss; Stefan (Concord, CA); Mezei; Michael (Halifax,
CA)
Assignee: BioZone Laboratories, Inc. (Pittsburgh, CA)
Appl. No.: 681303
Filed: July 22, 1996
Abstract
Substances, such as pharmaceuticals and cosmetics, are administered
encapsulated within a lipid vesicle, by iontophoresis. An iontophoretic
device which conforms to the contours of the body is also provided.
SUMMARY OF THE INVENTION
The present invention is directed to a method for
administration to a subject of a substance encapsulated within a lipid
vesicle, by iontophoresis. For example, the iontophoresis method of the
invention can be used to facilitate transport of a substance in or through
tissue/skin of a subject, that is in vivo (in or through the skin), ex
vivo (in or through excised skin) and in vivo (in or through artificial
skin).
The combination of liposomal delivery with iontophoresis is unexpectedly
beneficial, because, it is non-invasive, the liposome encapsulation makes
iontophoresis useful for non-polar substances and the iontophoresis
improves the penetration and localization of liposome-encapsulated
substance. The localization of the substance produce only a local effect,
without any systemic activity, which is definitely desirable for dermal
therapy.
The method of the invention can be used to obtain one or more of the
following: to enhance penetration, to better control delivery, to provide
a means of deeper delivery, to concentrate delivery, to localize delivery
by decreasing systemic action, to target different layers of the skin for
delivery, to increase the rate of delivery and the like. For example,
experiments with crystal violet, basic and acid fuchsin colloidal iron,
silver nitrate (used as markers) encapsulated in liposomes having
positive, or negative surface charge demonstrate this. Conventional
liposome anesthetic products are useful, but the lag time is usually 30 to
60 minutes. However, when charged liposome anesthetic products are used
with iontophoresis, the lag time can be reduced to 5-10 minutes. The
shorter lag time achieved by the iontophoresis makes the use of liposomal
local anesthetics (for minor surgery or venepuncture) more practical.
By use of the method of the invention, particularly with a multiphase
lipid vesicle compositions, substances can be incorporated into the
subject in a concentration higher than their water or lipid solubility.
Accordingly, the method using multiphase vesicle compositions is
particularly useful for administering substances with low lipid or water
solubility.
Claim 1 of 6 Claims
1. A method for administration of an substance selected
from the group consisting of an uncharged dye and uncharged anesthetic to
a subject comprising
applying directly to the skin or tissue of the subject a composition
comprising said substance encapsulated within liposomes having either a
positively or negatively charged surface by inotophoresis where the
electric current is from about 1 to about 3 milliamperes and the duration
is form about 1 to 15 minutes which causes dermal penetration.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|